Skip to content

International Baltic Conference on Healthy Longevity 2025 Preliminary Program

International advancement of research, development, education and policy for healthy longevity

The national program for preventing cardiovascular diseases and diabetes

Optimization of longevity therapeutics and development of new medical devices and pharmaceutical dosage systems

Pioneering Longevity Medicine: AI, Clinical Implementation & the Future

Hormone replacement therapy in postmenopausal women – is it a Longevity treatment?

Dr. Marta Kobzevaite, Longevity Alliance Baltic (LAB); Yuri Ostrinski, Riga Stradins University; Prof. Dr. Valdis Pirags, University of Latvia

Amit Goldman, EMBA, Longevity Education Hub; Prof. Evelyne Bischof, Sheba Longevity Center; Dr. Svjatoslavs Kistkins, Pauls Stradiņš Clinical University Hospital; Dr. Silvija Valdonė Alšauskė

New physiological models of aging and longevity. Or what terminal illness can teach about longevity?  

SGLT2 Inhibitors and GLP-1 Agonists – Modern Gerotherapeutics: A United Strategy or Separate Pathways? 

The Role of Retrotransposable Elements (Retrobiome) in Aging and Age-Related Diseases

Chronic Inflammation as the Hallmark of Aging: Association Between Elevated suPAR Biomarker and Accelerated Aging 

Microbiome: A pharmaceutical approach to longevity and disease prevention  

Insights into metabolic and endocrine regulation in longevity and chronobiology